Experience with long-term infliximab therapy in patients with ankylosing spondylitis
The duration of continuous use of infliximab is more than 8 years in patients with ankylosing spondylitis (AS). The efficiency of the drug persists in most patients during its long-term regular therapy. Objective. To evaluate the effectiveness and safety of long-term infliximab therapy in patients w...
Main Authors: | Oksana Alekseevna Rumyantseva, A G Bochkova, K Kh Kuzikyants, A V Levshakova, Sh F Erdes, E L Nasonov, Oksana Alekseyevna Rumyantseva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2010-12-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/951 |
Similar Items
-
THE FIRST EXPERIENCE IN USING ADALIMUMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: CLINICAL AND MRICOMPARISONS OF THE RESULTS OF THERAPY
by: A G Bochkova, et al.
Published: (2010-02-01) -
ATTEMPT OF OVERCOMING SECONDARY INEFFECTIVENESS OF INFLIXIMAB IN A PATIENT WITH ANKYLOSING SPONDYLITIS USING PLASMAPHERESIS (A CASE REPORT)
by: Oksana Alekseyevna Rumyantseva, et al.
Published: (2014-02-01) -
OPTIMIZATION OF X-RAY DIAGNOSIS OF ANKYLOSING SPONDYLITIS IN CLINICAL PRACTICE: IMPORTANCE OF A PLAIN X-RAY FILM OF THE PELVIS
by: A. V. Smirnov, et al.
Published: (2015-04-01) -
CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2018-05-01) -
Magnetic resonance imaging of sacroiliac joints in patients with seronegative spondyloarthritides
by: A. G. Bochkova, et al.
Published: (2007-06-01)